India's Sun Pharma and Israel's Moebius Medical published new data on MM-II, a non-opioid treatment for knee osteoarthritis.

II, a non-opioid treatment for knee osteoarthritis. Published in Osteoarthritis and Cartilage journal, the study reveals that ...

The Boao Lecheng International Medical Tourism Pilot Zone in Hainan province has released pricing for China's first batch of ...

In a preclinical study, two drugs targeting 'zombie cells' have been shown to treat the underlying cause of chronic low back pain. The condition affects millions of people worldwide. Current ...

Market OverviewThe Global Osteoarthritis Pain Drugs Market is valued at USD 10.32 Billion in 2023 and is projected to reach a value of USD 17.96 Billion by 2032 at a CAGR (Compound Annual Growth Rate) ...

The Department of Health - Abu Dhabi (DoH), has successfully completed a groundbreaking clinical trial in Abu Dhabi, in ...

Successful completion of groundbreaking stem cell trial for knee osteoarthritis marks a significant medical milestone.

Techniques that cause multipotent adult mesenchymal stem cells (MSCs ... MSCs to treat OA. Ulrich Nöth MD is an Assistant Professor of Orthopedic Surgery who specializes in knee and hip surgery.

Yoga and strengthening exercises both reduced knee pain in patients with knee osteoarthritis (OA) over 12 weeks, with no significant difference between them. Over 24 weeks, yoga led to modest ...

Based on time-specific analyses, participants with depression and knee osteoarthritis initially showed increased levels of physical activity followed by subsequent declines over time. The ...

Based on time-specific analyses, participants with depression and knee osteoarthritis initially showed increased levels of physical activity followed by subsequent declines over time. The relationship ...